Avtar Dhillon
Board of Directors
Genetics
CRB
Spain
Biography
Avtar Dhillon is a life sciences entrepreneur with more than 20 years experience building public companies through mergers and acquisitions, leading innovation in scientific, engineering and farming enterprises, securing government grants and NGO funding (more than $75 million U.S. to date), and building dominant IP portfolios through partnering. During his tenure as President and CEO at Inovio (NASDAQ: INO), he led the turnaround of the company through restructuring and acquisitions. Under his leadership, Inovio completed financing totalling over $250 million and several licensing deals with global pharma leaders Merck, Wyeth (now Pfizer) and Roche. Before joining Inovio, Avtar was Vice President of MDS Capital Corp., now Lumira Capital Corp., a leading healthcare venture capital organization. In 2016, he was appointed to the board of the Cannabis Association of Canada, which comprises key opinion leaders and executives who provide the Canadian government with their input to the formation of the recreational cannabis regulatory framework. Avtar practiced family medicine for over 12 years after receiving a B.Sc. (Honours) in Human Physiology and an M.D. from the University of British Columbia.
Research Interest
Genetics
